Carolyn Sasse

Bio:

Carolyn Sasse is Executive Vice President and Head of Clinical Operations & Quantitative Sciences at Astellas Pharma, where she leads the global design and execution of clinical trials across a diverse pipeline of innovative therapies. With deep expertise spanning clinical operations, data science and global development strategy, she is recognized for advancing smarter, patient-centered trials that accelerate the delivery of life?changing medicines. Carolyn has built her career at the intersection of science, data and operations guiding complex, high-impact programs from early development through registration. She played a pivotal role in the PADCEV & Xtandi clinical programs, helping redefine the standard of care in advanced bladder and prostate cancers, demonstrating her ability to translate scientific innovation into tangible patient outcomes. At Astellas, she is driving a transformation in clinical development by embedding patient insights into trial design, leveraging digital innovation and AI to improve efficiency, and advancing global trial strategies that balance regulatory requirements with equitable patient access.